During the past decade, MidLantic Urology conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 3 clinical trials were completed, i.e. on average, 13% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 3 clinical trials were completed. i.e. 15.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MidLantic Urology" #1 sponsor was "Janssen Research & Development, LLC" with 6 trials, followed by "Veru Inc." with 3 trials sponsored, "Allergan" with 1 trials sponsored, "Anchiano Therapeutics Israel Ltd." with 1 trials sponsored and "Angle plc" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MidLantic Urology" #1 collaborator was "Bayer" with 1 trials as a collaborator, "Carolina Urologic Research Center" with 1 trials as a collaborator and "MidLantic Urology, LLC" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MidLantic Urology" are "Prostate Cancer" (7 trials), "Prostatic Neoplasms" (3 trials), "Urinary Bladder Neoplasms" (3 trials), "Castration-resistant Prostate Cancer" (2 trials) and "Prostate Cancer Metastatic" (2 trials). Many other conditions were trialed in "MidLantic Urology" in a lesser frequency.

Most popular intervention types in "MidLantic Urology" are "Drug" (19 trials), "Biological" (4 trials), "Other" (3 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Apalutamide" (3 trials), "ADT" (2 trials), "Cetrelimab" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "MidLantic Urology" are 18 trials for "Male" genders and 6 trials for "All" genders.

Currently, there are NaN active trials in "MidLantic Urology". undefined are not yet recruiting, 11 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in MidLantic Urology, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in MidLantic Urology, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".